Last updated 2026-07-26
Total raised
—
Last: Debt Financing 2026-03
Stage
Public
Founded
2017
Headcount
11
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences
About
InnoCan Pharma is a pharmaceutical technology company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, InnoCan focuses on developing innovative drug delivery platform technologies comprised of cannabinoid science to treat various conditions and improve patients' quality of life. This segment involves two drug delivery technologies: LPT CBD-loaded liposome platform and CLX CBD-loaded exosomes platform. In the consumer wellness segment, InnoCan develops and markets a wide portfolio of innovative self-care products to promote a healthier lifestyle.
Headcount over time
11 employees (2026-09) · 1 point
Offices
Herzliya, Israel · HQ / main office
Q&A
- What is InnoCan Pharma's primary focus?
- InnoCan Pharma is a pharmaceutical technology company developing innovative drug delivery platforms and products using cannabinoids, operating in both Pharmaceutical and Consumer Wellness segments.
- When was InnoCan Pharma founded and where is its headquarters?
- InnoCan Pharma was founded in October 2017 and is headquartered in Herzliya, Israel.
- What is the current employee count for InnoCan Pharma?
- InnoCan Pharma has 11-50 employees.
- What was InnoCan Pharma's most recent funding round?
- In March 2026, InnoCan Pharma secured Debt Financing with Tamar Innovest Limited.
- What was the total amount raised by InnoCan Pharma to date?
- InnoCan Pharma has raised a total of $20,120,000 USD.
- What is InnoCan Pharma's status as a company?
- InnoCan Pharma is a public company.
- What are the key drug delivery technologies InnoCan Pharma is developing?
- InnoCan Pharma is developing two drug delivery technologies: LPT CBD-loaded liposome platform and CLX CBD-loaded exosomes platform.
- Who are the founders of InnoCan Pharma?
- The founders of InnoCan Pharma are Ron Mayron, Iris Bincovich, Nir Avram, and Yoram Drucker.
Team · 8
Iris Bincovich
Founder · Chief Executive Officer
Roni Kamhi
Chief Operating Officer
Nelson Halpern
Chief Financial Officer
Eyal Kalo
Vice President, R&D
Eyal Flom
General Counsel
Peter Bloch
Board Member
Joshua Lintern
Board Member
Ralph C.l. Bossino
Board Member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B2CB2CB2B
Highlights
Patents
Tags
diabetesdrug-deliverypharmaceuticalstherapeuticscannabispatientstopical-treatmentdermatologypain-reliefpatent-pendingwellnesspharma-companieswomen-healthalzheimers-diseasetreatmentsepilepsyecommercecell-therapymedical-cannabisinhalationcosmetics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | innocanpharma.com |
|---|---|
| linkedin.com/company/28636009 |
Identifiers & details
| Legal name | Innocan Pharma Corporation |
|---|---|
| Founded | 2017-10 |
| Employees (exact) | 11 |
Radar intelligence
Patents
| EPO | 10 |
|---|
Web history (Wayback)
| Domain | innocanpharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515732881 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-10-18 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — annual_report (2) |
| Registered address | אריק איינשטיין 3 הרצליה |
Recent registry events
| Date | Event |
|---|---|
| 2026-01-14 | דו~ח שנתי-הוספת דירקטור |
| 2026-01-14 | דו~ח שנתי-הסרת דירקטור |